Drug recall · July 4, 2012
Mefloquine HCL Tablets recall
Why: Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dose Tablets (5x5) Carton: NDC 0555-0171-78
- Lots / codes
Lot # 34000741A; Expiration date: 7/2013
- Quantity
- 4188 cartons (5 X 5 blisterpacks)
- Company
- Teva Pharmaceuticals USA, Inc., Sellersville, PA
- Distribution
- Nationwide
- Initiated
- April 2, 2012 · Voluntary: Firm initiated
- Classified
- June 26, 2012
- Reported
- July 4, 2012
- Ended
- March 22, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Mefloquine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.